PD1 is a key inhibitory receptor significantly expressed on exhausted CD8 T cells, mediating immune escape in tumor cells by limiting the capabilities of TCR and CD28, upon interactions with its ligands PD-L1 or PD-L2 on T cells [97]. This evidence concerns the gene CD8A and neoplasm.